[fusion_builder_container type=»flex» hundred_percent=»yes» hundred_percent_height=»no» min_height=»» hundred_percent_height_scroll=»no» align_content=»stretch» flex_align_items=»flex-start» flex_justify_content=»flex-start» flex_column_spacing=»» hundred_percent_height_center_content=»yes» equal_height_columns=»no» container_tag=»div» menu_anchor=»» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» status=»published» publish_date=»» class=»» id=»» margin_top_medium=»» margin_bottom_medium=»» margin_top_small=»» margin_bottom_small=»» margin_top=»» margin_bottom=»» padding_top_medium=»» padding_right_medium=»» padding_bottom_medium=»» padding_left_medium=»» padding_top_small=»» padding_right_small=»0px» padding_bottom_small=»» padding_left_small=»0px» padding_top=»» padding_right=»» padding_bottom=»» padding_left=»» link_color=»» link_hover_color=»» border_sizes_top=»» border_sizes_right=»» border_sizes_bottom=»» border_sizes_left=»» border_color=»» border_style=»solid» box_shadow=»no» box_shadow_vertical=»» box_shadow_horizontal=»» box_shadow_blur=»0″ box_shadow_spread=»0″ box_shadow_color=»» box_shadow_style=»» z_index=»» overflow=»» gradient_start_color=»» gradient_end_color=»» gradient_start_position=»0″ gradient_end_position=»100″ gradient_type=»linear» radial_direction=»center center» linear_angle=»180″ background_color=»» background_image=»» background_position=»center center» background_repeat=»no-repeat» fade=»no» background_parallax=»none» enable_mobile=»no» parallax_speed=»0.3″ background_blend_mode=»none» video_mp4=»» video_webm=»» video_ogv=»» video_url=»» video_aspect_ratio=»16:9″ video_loop=»yes» video_mute=»yes» video_preview_image=»» render_logics=»» absolute=»off» absolute_devices=»small,medium,large» sticky=»off» sticky_devices=»small-visibility,medium-visibility,large-visibility» sticky_background_color=»» sticky_height=»» sticky_offset=»» sticky_transition_offset=»0″ scroll_offset=»0″ animation_type=»» animation_direction=»left» animation_speed=»0.3″ animation_offset=»» filter_hue=»0″ filter_saturation=»100″ filter_brightness=»100″ filter_contrast=»100″ filter_invert=»0″ filter_sepia=»0″ filter_opacity=»100″ filter_blur=»0″ filter_hue_hover=»0″ filter_saturation_hover=»100″ filter_brightness_hover=»100″ filter_contrast_hover=»100″ filter_invert_hover=»0″ filter_sepia_hover=»0″ filter_opacity_hover=»100″ filter_blur_hover=»0″ admin_label=»Factor News Post»][fusion_builder_row][fusion_builder_column type=»1_1″ layout=»2_3″ align_self=»auto» content_layout=»column» align_content=»flex-start» valign_content=»flex-start» content_wrap=»wrap» spacing=»» center_content=»no» link=»» target=»_self» min_height=»» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» sticky_display=»normal,sticky» class=»» id=»» type_medium=»» type_small=»» order_medium=»0″ order_small=»0″ dimension_spacing_medium=»» dimension_spacing_small=»» dimension_spacing=»» dimension_margin_medium=»» dimension_margin_small=»» margin_top=»» margin_bottom=»» padding_medium=»» padding_small=»» padding_top=»» padding_right=»» padding_bottom=»» padding_left=»» hover_type=»none» border_sizes=»» border_color=»» border_style=»solid» border_radius=»» box_shadow=»no» dimension_box_shadow=»» box_shadow_blur=»0″ box_shadow_spread=»0″ box_shadow_color=»» box_shadow_style=»» background_type=»single» gradient_start_color=»» gradient_end_color=»» gradient_start_position=»0″ gradient_end_position=»100″ gradient_type=»linear» radial_direction=»center center» linear_angle=»180″ background_color=»» background_image=»» background_image_id=»» background_position=»left top» background_repeat=»no-repeat» background_blend_mode=»none» render_logics=»» filter_type=»regular» filter_hue=»0″ filter_saturation=»100″ filter_brightness=»100″ filter_contrast=»100″ filter_invert=»0″ filter_sepia=»0″ filter_opacity=»100″ filter_blur=»0″ filter_hue_hover=»0″ filter_saturation_hover=»100″ filter_brightness_hover=»100″ filter_contrast_hover=»100″ filter_invert_hover=»0″ filter_sepia_hover=»0″ filter_opacity_hover=»100″ filter_blur_hover=»0″ animation_type=»» animation_direction=»left» animation_speed=»0.3″ animation_offset=»» last=»true» border_position=»all» first=»true» spacing_right=»»][fusion_imageframe image_id=»5114|full» max_width=»» sticky_max_width=»» skip_lazy_load=»» style_type=»» blur=»» stylecolor=»» hover_type=»none» bordersize=»» bordercolor=»» borderradius=»» align_medium=»none» align_small=»none» align=»none» margin_top=»» margin_right=»» margin_bottom=»» margin_left=»» lightbox=»no» gallery_id=»» lightbox_image=»» lightbox_image_id=»» alt=»» link=»» linktarget=»_self» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» sticky_display=»normal,sticky» class=»» id=»» animation_type=»» animation_direction=»left» animation_speed=»0.3″ animation_offset=»» filter_hue=»0″ filter_saturation=»100″ filter_brightness=»100″ filter_contrast=»100″ filter_invert=»0″ filter_sepia=»0″ filter_opacity=»100″ filter_blur=»0″ filter_hue_hover=»0″ filter_saturation_hover=»100″ filter_brightness_hover=»100″ filter_contrast_hover=»100″ filter_invert_hover=»0″ filter_sepia_hover=»0″ filter_opacity_hover=»100″ filter_blur_hover=»0″]https://factoronline.mx/wp-content/uploads/2022/01/271596544_338089634985666_2111932157367715313_n.jpg[/fusion_imageframe][fusion_separator style_type=»default» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» sticky_display=»normal,sticky» class=»» id=»» flex_grow=»0″ top_margin=»» bottom_margin=»20px» width=»» alignment=»center» border_size=»» sep_color=»» icon=»» icon_size=»» icon_color=»» icon_circle=»» icon_circle_color=»» /][fusion_title title_type=»text» rotation_effect=»bounceIn» display_time=»1200″ highlight_effect=»circle» loop_animation=»off» highlight_width=»9″ highlight_top_margin=»0″ before_text=»» rotation_text=»» highlight_text=»» after_text=»» title_link=»off» link_url=»» link_target=»_self» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» sticky_display=»normal,sticky» class=»» id=»» content_align_medium=»» content_align_small=»» content_align=»center» size=»1″ font_size=»» animated_font_size=»» fusion_font_family_title_font=»» fusion_font_variant_title_font=»» line_height=»» letter_spacing=»» text_shadow=»no» text_shadow_vertical=»» text_shadow_horizontal=»» text_shadow_blur=»0″ text_shadow_color=»» margin_top_medium=»» margin_right_medium=»» margin_bottom_medium=»» margin_left_medium=»» margin_top_small=»» margin_right_small=»» margin_bottom_small=»» margin_left_small=»» margin_top=»» margin_right=»» margin_bottom=»» margin_left=»» margin_top_mobile=»» margin_bottom_mobile=»» text_color=»#1968a3″ animated_text_color=»» gradient_font=»no» gradient_start_color=»» gradient_end_color=»» gradient_start_position=»0″ gradient_end_position=»100″ gradient_type=»linear» radial_direction=»center center» linear_angle=»180″ highlight_color=»» style_type=»default» sep_color=»» link_color=»» link_hover_color=»» animation_type=»» animation_direction=»left» animation_speed=»0.3″ animation_offset=»»]

México – 8/Ene/2022

[/fusion_title][fusion_separator style_type=»default» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» sticky_display=»normal,sticky» class=»» id=»» flex_grow=»0″ top_margin=»» bottom_margin=»50px» width=»» alignment=»center» border_size=»» sep_color=»» icon=»» icon_size=»» icon_color=»» icon_circle=»» icon_circle_color=»» /][fusion_text columns=»» column_min_width=»» column_spacing=»» rule_style=»default» rule_size=»» rule_color=»» content_alignment_medium=»» content_alignment_small=»» content_alignment=»» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» sticky_display=»normal,sticky» class=»» id=»» margin_top=»» margin_right=»» margin_bottom=»» margin_left=»» font_size=»» fusion_font_family_text_font=»» fusion_font_variant_text_font=»» line_height=»» letter_spacing=»» text_color=»#000000″ animation_type=»» animation_direction=»left» animation_speed=»0.3″ animation_offset=»»]

La Comisión Federal para la Protección contra Riesgos Sanitarios (Cofepris), autorizó el medicamento Molnupiravir como tratamiento oral contra el covid.

Este medicamento será destinado para atender pacientes con covid leve o moderado, y con alto riesgo de complicaciones.

Las autoridades sanitarias mexicanas comenzaron la evaluación de este medicamento durante la semana del 23 de diciembre de 2021, cuando se tuvo intercambio de información técnica con otras agencias regulatorias; este proceso de transferencia de conocimiento se realiza gracias al reliance, o convergencia regulatoria, declarado prioridad en Cofepris en agosto del año pasado.

Mediante un comunicado, la dependencia aseguró que la aprobación de este medicamento ocurre en tiempo récord e incluso la autorización ocurre antes que en otros países.

La píldora covid actúa introduciendo errores en el código genético del virus SARS-CoV-2, evitando que se replique en el organismo. Se trata de un medicamento oral suministrado mediante cápsulas por cinco días.

Por último, la Cofepris aclara que el medicamento NO está autorizado para la venta al público. En caso de identificar la venta se debe denunciar mediante la página gob.mx/Cofepris ya que su consumo irregular constituye un riesgo a la salud por ser de dudosa procedencia.

[/fusion_text][fusion_separator style_type=»default» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» sticky_display=»normal,sticky» class=»» id=»» flex_grow=»0″ top_margin=»» bottom_margin=»50px» width=»» alignment=»center» border_size=»» sep_color=»» icon=»» icon_size=»» icon_color=»» icon_circle=»» icon_circle_color=»» /][fusion_title title_type=»text» rotation_effect=»bounceIn» display_time=»1200″ highlight_effect=»circle» loop_animation=»off» highlight_width=»9″ highlight_top_margin=»0″ before_text=»» rotation_text=»» highlight_text=»» after_text=»» title_link=»off» link_url=»» link_target=»_self» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» sticky_display=»normal,sticky» class=»» id=»» content_align_medium=»» content_align_small=»» content_align=»center» size=»1″ font_size=»40px» animated_font_size=»» fusion_font_family_title_font=»» fusion_font_variant_title_font=»» line_height=»» letter_spacing=»» text_shadow=»no» text_shadow_vertical=»» text_shadow_horizontal=»» text_shadow_blur=»0″ text_shadow_color=»» margin_top_medium=»» margin_right_medium=»» margin_bottom_medium=»» margin_left_medium=»» margin_top_small=»» margin_right_small=»» margin_bottom_small=»» margin_left_small=»» margin_top=»» margin_right=»» margin_bottom=»» margin_left=»» margin_top_mobile=»» margin_bottom_mobile=»» text_color=»#000000″ animated_text_color=»» highlight_color=»» style_type=»default» sep_color=»» link_color=»» link_hover_color=»» animation_type=»» animation_direction=»left» animation_speed=»0.3″ animation_offset=»»]

¡Síguenos en nuestras redes sociales!

[/fusion_title][fusion_separator style_type=»default» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» sticky_display=»normal,sticky» class=»» id=»» flex_grow=»0″ top_margin=»» bottom_margin=»30px» width=»» alignment=»center» border_size=»» sep_color=»» icon=»» icon_size=»» icon_color=»» icon_circle=»» icon_circle_color=»» /][fusion_social_links blogger=»» deviantart=»» discord=»» digg=»» dribbble=»» dropbox=»» facebook=»https://www.facebook.com/Factor-News-106400478154584″ flickr=»» forrst=»» instagram=»https://instagram.com/factoronline2021/» linkedin=»» myspace=»» paypal=»» pinterest=»» reddit=»» rss=»» skype=»» soundcloud=»» spotify=»» tiktok=»» tumblr=»» twitch=»» twitter=»https://twitter.com/FactorNews2020″ vimeo=»» vk=»» wechat=»» whatsapp=»» xing=»» yahoo=»» yelp=»» youtube=»» email=»» phone=»» show_custom=»no» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» sticky_display=»normal,sticky» class=»» id=»» font_size=»35px» icons_boxed=»yes» icons_boxed_radius=»50px» color_type=»custom» icon_colors=»#ffffff» box_colors=»#ffd330″ tooltip_placement=»» alignment=»center» /][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]


FacebooktwitterlinkedininstagramFacebooktwitterlinkedininstagram
Call Now Button